Physiomics Management
Management criteria checks 2/4
Physiomics' CEO is Peter Sargent, appointed in Sep 2023, has a tenure of 1.17 years. total yearly compensation is £93.34K, comprised of 78.2% salary and 21.8% bonuses, including company stock and options. directly owns 0.23% of the company’s shares, worth £3.10K. The average tenure of the management team and the board of directors is 2.2 years and 2.6 years respectively.
Key information
Peter Sargent
Chief executive officer
UK£93.3k
Total compensation
| CEO salary percentage | 78.2% |
| CEO tenure | 1.2yrs |
| CEO ownership | 0.2% |
| Management average tenure | 2.2yrs |
| Board average tenure | 2.6yrs |
Recent management updates
Recent updates
It's Unlikely That Shareholders Will Increase Physiomics Plc's (LON:PYC) Compensation By Much This Year
Nov 15
Here's Why We Think Physiomics Plc's (LON:PYC) CEO Compensation Looks Fair
Nov 17Here's Why Shareholders Will Not Be Complaining About Physiomics Plc's (LON:PYC) CEO Pay Packet
Nov 16What Can We Conclude About Physiomics' (LON:PYC) CEO Pay?
Feb 08
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | UK£93k | UK£73k | -UK£609k |
Compensation vs Market: Peter's total compensation ($USD117.08K) is below average for companies of similar size in the UK market ($USD354.57K).
Compensation vs Earnings: Insufficient data to compare Peter's compensation with company performance.
CEO
Peter Sargent (46 yo)
1.2yrs
Tenure
UK£93,335
Compensation
Dr. Peter Joseph Sargent is Chief Operating Officer of Physiomics Plc from September 04, 2023 and serves as its Chief Executive Officer and Director from January 22, 2024. He joined Physiomics Plc in Septe...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, COO & Director | 1.2yrs | UK£93.34k | 0.23% £ 3.1k | |
| Co-Founder & Member of Scientific Advisory Board | no data | UK£2.63k | no data | |
| Head of Finance & Company Secretary | 8.5yrs | no data | no data | |
| Head of Business Development | 3.3yrs | no data | no data | |
| Head of Biostatistics | 1.1yrs | no data | no data | |
| Head of Quantitative Pharmacology & Data Science | no data | no data | no data | |
| Consultant & Member of Scientific Advisory Board | 9.3yrs | no data | no data | |
| Consultant & Member of Scientific Advisory Board | no data | no data | no data |
2.2yrs
Average Tenure
56yo
Average Age
Experienced Management: PYC's management team is considered experienced (2.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, COO & Director | less than a year | UK£93.34k | 0.23% £ 3.1k | |
| Co-Founder & Member of Scientific Advisory Board | no data | UK£2.63k | no data | |
| Consultant & Member of Scientific Advisory Board | 9.3yrs | no data | no data | |
| Consultant & Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Non-Executive Director | 2.2yrs | UK£20.00k | no data | |
| Independent Non-Executive Director | 2.6yrs | UK£20.00k | no data | |
| Non-Executive Chairman | 8.5yrs | UK£67.43k | 0.93% £ 12.7k |
2.6yrs
Average Tenure
57yo
Average Age
Experienced Board: PYC's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.